A detailed history of Chapman Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Chapman Financial Group, LLC holds 3,845 shares of ABT stock, worth $499,965. This represents 0.36% of its overall portfolio holdings.

Number of Shares
3,845
Holding current value
$499,965
% of portfolio
0.36%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$120.51 - $136.62 $463,360 - $525,303
3,845 New
3,845 $515 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Chapman Financial Group, LLC Portfolio

Follow Chapman Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chapman Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chapman Financial Group, LLC with notifications on news.